ARGANOVA

This brand name is authorized in Spain, France, Netherlands, Romania

Active ingredients

The drug ARGANOVA contains one active pharmaceutical ingredient (API):

1 Argatroban UNII IY90U61Z3S - ARGATROBAN

Argatroban, a synthetic L-arginine derivative, is a direct thrombin inhibitor (molecular weight 526.65) that binds reversibly to thrombin. Argatroban exerts its anticoagulant effect independently of antithrombin III and inhibits fibrin formation; activation of coagulation factors V, VIII and XIII; activation of protein C; and platelet aggregation. Read about Argatroban

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AE03	Argatroban	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors
Discover more medicines within B01AE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 74548
Country: FR	Base de données publique des médicaments	Identifier(s): 60720216, 65905051
Country: NL	Z-Index G-Standaard	Identifier(s): 15103994
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 100838
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68780001